Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2020 / Nov / A Window to Neurodegeneration?
Neuro-ophthalmology Research & Innovations

A Window to Neurodegeneration?

Detecting neurodegeneration with a protein biomarker found in blood, CSF – and now the eye

By Olivia Gaskill 11/30/2020 1 min read

Share

Neurofilament light chain (NfL) is being investigated as a potential biomarker of neurodegeneration after it was found in cerebrospinal fluid and blood – but researchers at Boston Medical Center have also detected the protein in the vitreous humor.

Collecting eye fluid samples from ophthalmic surgery patients, they investigated the presence and association of NfL with known biomarkers of neurodegenerative disease. NfL was positively associated with t-tau, amyloid beta, and select inflammatory and vascular proteins in the vitreous humor. It was not associated with existing eye conditions, suggesting it is not influenced by eye disease.

Although further research is needed to validate whether ophthalmic NfL is a definitive indicator of neurodegeneration, the authors hope their findings will help detect disease before irreversible atrophy begins.

References

  1. ML Subramanian et al., Alz Res Ther, 12, 1 (2020). PMID: 32943089.

About the Author(s)

Olivia Gaskill

Associate Editor of The Pathologist.

More Articles by Olivia Gaskill

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: